Flublok Quadrivalent provided comparable safety and immunogenicity compared with Fluarix Quadrivalent inactivated influenza vaccine in pediatric patients, particularly those aged 9 to 17 years, according to research published in Pediatrics.
“Seasonal influenza vaccines have transitioned recently to quadrivalent formulations containing antigens representing both influenza B lineages (Yamagata and Victoria) as well as conventional influenza A subtypes H1N1 and H3N2,” Lisa M. Dunkle, MD, of Protein Science Corp., and colleagues wrote. “The second influenza B lineage has been added to address the high frequency of circulation of both B lineages in a single season, and the common circulation of influenza B lineage mismatched with the vaccine strain.”
This activity is supported by an educational grant from Genentech, Inc.
American Academy of Pediatrics National Conference & Exhibition
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.